Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Relkin

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Experimental Gerontology|June 28, 2002
Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individualsMarc E Weksler, Norman Relkin, Rimma Turkenich, et al.
Annals of Neurology|December 15, 2006
Cerebrospinal fluid proteomic biomarkers for Alzheimer's diseaseErin J Finehout, Zsofia Franck, Leila H Choe, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 22, 2004
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL studyL Adrienne Cupples, Lindsay A Farrer, A Dessa Sadovnick, et al.
Human Brain Mapping|March 27, 2016
Structural connectome disruption at baseline predicts 6-months post-stroke outcomeAmy Kuceyeski, Babak B Navi, Hooman Kamel, et al.
AJNR. American Journal of Neuroradiology|January 21, 2003
Increased diffusion in the brain of professional boxers: a preclinical sign of traumatic brain injury?Lijuan Zhang, Lisa D Ravdin, Norman Relkin, et al.
The Journal of Infection|November 20, 2020
Comparison of saliva and nasopharyngeal swab SARS-CoV-2 RT-qPCR testing in a community settingMonique Torres, Katherine Collins, Mariah Corbit, et al.
Human Brain Mapping|February 7, 2015
Exploring the brain's structural connectome: A quantitative stroke lesion-dysfunction mapping studyAmy Kuceyeski, Babak B Navi, Hooman Kamel, et al.
Journal of Neuroimmunology|July 20, 2010
Measurement of anti-beta amyloid antibodies in human bloodPaul Szabo, Diana M Mujalli, Matthew L Rotondi, et al.
Fluids and Barriers of the CNS|May 1, 2015
MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic normal pressure hydrocephalusMilos Ivkovic, Martin Reiss-Zimmermann, Heather Katzen, et al.
Neurochemistry International|April 12, 2003
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's diseaseStefan Lorenzl, David S Albers, Norman Relkin, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Experimental Gerontology|June 28, 2002
Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individualsMarc E Weksler, Norman Relkin, Rimma Turkenich, et al.
Annals of Neurology|December 15, 2006
Cerebrospinal fluid proteomic biomarkers for Alzheimer's diseaseErin J Finehout, Zsofia Franck, Leila H Choe, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 22, 2004
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL studyL Adrienne Cupples, Lindsay A Farrer, A Dessa Sadovnick, et al.
Human Brain Mapping|March 27, 2016
Structural connectome disruption at baseline predicts 6-months post-stroke outcomeAmy Kuceyeski, Babak B Navi, Hooman Kamel, et al.
AJNR. American Journal of Neuroradiology|January 21, 2003
Increased diffusion in the brain of professional boxers: a preclinical sign of traumatic brain injury?Lijuan Zhang, Lisa D Ravdin, Norman Relkin, et al.
The Journal of Infection|November 20, 2020
Comparison of saliva and nasopharyngeal swab SARS-CoV-2 RT-qPCR testing in a community settingMonique Torres, Katherine Collins, Mariah Corbit, et al.
Human Brain Mapping|February 7, 2015
Exploring the brain's structural connectome: A quantitative stroke lesion-dysfunction mapping studyAmy Kuceyeski, Babak B Navi, Hooman Kamel, et al.
Journal of Neuroimmunology|July 20, 2010
Measurement of anti-beta amyloid antibodies in human bloodPaul Szabo, Diana M Mujalli, Matthew L Rotondi, et al.
Fluids and Barriers of the CNS|May 1, 2015
MRI assessment of the effects of acetazolamide and external lumbar drainage in idiopathic normal pressure hydrocephalusMilos Ivkovic, Martin Reiss-Zimmermann, Heather Katzen, et al.
Neurochemistry International|April 12, 2003
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's diseaseStefan Lorenzl, David S Albers, Norman Relkin, et al.
Pageof 4